nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—multiple sclerosis	0.836	1	CbGaD
Mivacurium—BCHE—Triamcinolone—multiple sclerosis	0.0693	1	CbGbCtD
Mivacurium—Hypoxemia—Methotrexate—multiple sclerosis	0.00397	0.0435	CcSEcCtD
Mivacurium—Doxacurium chloride—BCHE—multiple sclerosis	0.00353	1	CrCbGaD
Mivacurium—Injection site reaction—Cladribine—multiple sclerosis	0.00242	0.0265	CcSEcCtD
Mivacurium—Wheezing—Cladribine—multiple sclerosis	0.00236	0.0259	CcSEcCtD
Mivacurium—Bradycardia—Fingolimod—multiple sclerosis	0.00219	0.0241	CcSEcCtD
Mivacurium—Phlebitis—Cladribine—multiple sclerosis	0.00205	0.0225	CcSEcCtD
Mivacurium—Cardiac disorder—Fingolimod—multiple sclerosis	0.002	0.0219	CcSEcCtD
Mivacurium—Angiopathy—Fingolimod—multiple sclerosis	0.00195	0.0214	CcSEcCtD
Mivacurium—Mediastinal disorder—Fingolimod—multiple sclerosis	0.00194	0.0213	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00159	0.0174	CcSEcCtD
Mivacurium—Skin disorder—Fingolimod—multiple sclerosis	0.00149	0.0163	CcSEcCtD
Mivacurium—Hypotension—Fingolimod—multiple sclerosis	0.00143	0.0157	CcSEcCtD
Mivacurium—Phlebitis—Mitoxantrone—multiple sclerosis	0.00135	0.0148	CcSEcCtD
Mivacurium—Hypoxia—Methotrexate—multiple sclerosis	0.00125	0.0138	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Mitoxantrone—multiple sclerosis	0.0012	0.0131	CcSEcCtD
Mivacurium—Wheezing—Triamcinolone—multiple sclerosis	0.00117	0.0128	CcSEcCtD
Mivacurium—Cardiac disorder—Cladribine—multiple sclerosis	0.00113	0.0124	CcSEcCtD
Mivacurium—Angiopathy—Cladribine—multiple sclerosis	0.00111	0.0122	CcSEcCtD
Mivacurium—Immune system disorder—Cladribine—multiple sclerosis	0.0011	0.0121	CcSEcCtD
Mivacurium—Mediastinal disorder—Cladribine—multiple sclerosis	0.0011	0.0121	CcSEcCtD
Mivacurium—Arrhythmia—Cladribine—multiple sclerosis	0.00109	0.012	CcSEcCtD
Mivacurium—Erythema—Cladribine—multiple sclerosis	0.00106	0.0117	CcSEcCtD
Mivacurium—Dizziness—Fingolimod—multiple sclerosis	0.00101	0.0111	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Prednisolone—multiple sclerosis	0.000983	0.0108	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Triamcinolone—multiple sclerosis	0.000904	0.00992	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methylprednisolone—multiple sclerosis	0.000902	0.0099	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000899	0.00986	CcSEcCtD
Mivacurium—Immune system disorder—Azathioprine—multiple sclerosis	0.000897	0.00984	CcSEcCtD
Mivacurium—Mediastinal disorder—Azathioprine—multiple sclerosis	0.000895	0.00982	CcSEcCtD
Mivacurium—Arrhythmia—Azathioprine—multiple sclerosis	0.000887	0.00973	CcSEcCtD
Mivacurium—Tachycardia—Cladribine—multiple sclerosis	0.000847	0.00929	CcSEcCtD
Mivacurium—Skin disorder—Cladribine—multiple sclerosis	0.000843	0.00924	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Dexamethasone—multiple sclerosis	0.000821	0.009	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Betamethasone—multiple sclerosis	0.000821	0.009	CcSEcCtD
Mivacurium—Bradycardia—Mitoxantrone—multiple sclerosis	0.000817	0.00896	CcSEcCtD
Mivacurium—Hypotension—Cladribine—multiple sclerosis	0.000811	0.00889	CcSEcCtD
Mivacurium—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000743	0.00814	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000731	0.00802	CcSEcCtD
Mivacurium—Arrhythmia—Mitoxantrone—multiple sclerosis	0.000717	0.00786	CcSEcCtD
Mivacurium—Erythema—Mitoxantrone—multiple sclerosis	0.000699	0.00766	CcSEcCtD
Mivacurium—Urticaria—Cladribine—multiple sclerosis	0.000689	0.00756	CcSEcCtD
Mivacurium—Skin disorder—Azathioprine—multiple sclerosis	0.000685	0.00752	CcSEcCtD
Mivacurium—Bradycardia—Prednisolone—multiple sclerosis	0.00067	0.00735	CcSEcCtD
Mivacurium—Hypotension—Azathioprine—multiple sclerosis	0.000659	0.00723	CcSEcCtD
Mivacurium—Bradycardia—Triamcinolone—multiple sclerosis	0.000616	0.00676	CcSEcCtD
Mivacurium—Bradycardia—Methylprednisolone—multiple sclerosis	0.000615	0.00675	CcSEcCtD
Mivacurium—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000597	0.00655	CcSEcCtD
Mivacurium—Arrhythmia—Prednisolone—multiple sclerosis	0.000588	0.00645	CcSEcCtD
Mivacurium—Dizziness—Cladribine—multiple sclerosis	0.000574	0.00629	CcSEcCtD
Mivacurium—Erythema—Prednisolone—multiple sclerosis	0.000573	0.00629	CcSEcCtD
Mivacurium—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00057	0.00625	CcSEcCtD
Mivacurium—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.000561	0.00615	CcSEcCtD
Mivacurium—Bradycardia—Dexamethasone—multiple sclerosis	0.000559	0.00614	CcSEcCtD
Mivacurium—Bradycardia—Betamethasone—multiple sclerosis	0.000559	0.00614	CcSEcCtD
Mivacurium—Tachycardia—Mitoxantrone—multiple sclerosis	0.000557	0.0061	CcSEcCtD
Mivacurium—Skin disorder—Mitoxantrone—multiple sclerosis	0.000554	0.00608	CcSEcCtD
Mivacurium—Angiopathy—Methylprednisolone—multiple sclerosis	0.000548	0.00601	CcSEcCtD
Mivacurium—Rash—Cladribine—multiple sclerosis	0.000547	0.006	CcSEcCtD
Mivacurium—Dermatitis—Cladribine—multiple sclerosis	0.000546	0.00599	CcSEcCtD
Mivacurium—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000546	0.00599	CcSEcCtD
Mivacurium—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000545	0.00597	CcSEcCtD
Mivacurium—Arrhythmia—Triamcinolone—multiple sclerosis	0.000541	0.00593	CcSEcCtD
Mivacurium—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00054	0.00592	CcSEcCtD
Mivacurium—Hypotension—Mitoxantrone—multiple sclerosis	0.000533	0.00584	CcSEcCtD
Mivacurium—Erythema—Triamcinolone—multiple sclerosis	0.000527	0.00578	CcSEcCtD
Mivacurium—Erythema—Methylprednisolone—multiple sclerosis	0.000526	0.00577	CcSEcCtD
Mivacurium—Angiopathy—Betamethasone—multiple sclerosis	0.000499	0.00547	CcSEcCtD
Mivacurium—Angiopathy—Dexamethasone—multiple sclerosis	0.000499	0.00547	CcSEcCtD
Mivacurium—Arrhythmia—Betamethasone—multiple sclerosis	0.000491	0.00538	CcSEcCtD
Mivacurium—Arrhythmia—Dexamethasone—multiple sclerosis	0.000491	0.00538	CcSEcCtD
Mivacurium—Bradycardia—Prednisone—multiple sclerosis	0.000487	0.00534	CcSEcCtD
Mivacurium—Erythema—Dexamethasone—multiple sclerosis	0.000478	0.00525	CcSEcCtD
Mivacurium—Erythema—Betamethasone—multiple sclerosis	0.000478	0.00525	CcSEcCtD
Mivacurium—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000468	0.00513	CcSEcCtD
Mivacurium—Dizziness—Azathioprine—multiple sclerosis	0.000466	0.00512	CcSEcCtD
Mivacurium—Tachycardia—Prednisolone—multiple sclerosis	0.000457	0.00501	CcSEcCtD
Mivacurium—Urticaria—Mitoxantrone—multiple sclerosis	0.000453	0.00497	CcSEcCtD
Mivacurium—Rash—Azathioprine—multiple sclerosis	0.000445	0.00488	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000445	0.00488	CcSEcCtD
Mivacurium—Dermatitis—Azathioprine—multiple sclerosis	0.000444	0.00487	CcSEcCtD
Mivacurium—Flushing—Prednisone—multiple sclerosis	0.000444	0.00487	CcSEcCtD
Mivacurium—Angiopathy—Prednisone—multiple sclerosis	0.000434	0.00476	CcSEcCtD
Mivacurium—Immune system disorder—Prednisone—multiple sclerosis	0.000432	0.00474	CcSEcCtD
Mivacurium—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00043	0.00472	CcSEcCtD
Mivacurium—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000429	0.00471	CcSEcCtD
Mivacurium—Arrhythmia—Prednisone—multiple sclerosis	0.000427	0.00469	CcSEcCtD
Mivacurium—Tachycardia—Triamcinolone—multiple sclerosis	0.00042	0.00461	CcSEcCtD
Mivacurium—Tachycardia—Methylprednisolone—multiple sclerosis	0.000419	0.0046	CcSEcCtD
Mivacurium—Skin disorder—Methylprednisolone—multiple sclerosis	0.000417	0.00457	CcSEcCtD
Mivacurium—Erythema—Prednisone—multiple sclerosis	0.000417	0.00457	CcSEcCtD
Mivacurium—Hypotension—Methylprednisolone—multiple sclerosis	0.000401	0.0044	CcSEcCtD
Mivacurium—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00039	0.00428	CcSEcCtD
Mivacurium—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00039	0.00428	CcSEcCtD
Mivacurium—Tachycardia—Dexamethasone—multiple sclerosis	0.000381	0.00418	CcSEcCtD
Mivacurium—Tachycardia—Betamethasone—multiple sclerosis	0.000381	0.00418	CcSEcCtD
Mivacurium—Urticaria—Prednisolone—multiple sclerosis	0.000372	0.00408	CcSEcCtD
Mivacurium—Cardiac disorder—Methotrexate—multiple sclerosis	0.000371	0.00407	CcSEcCtD
Mivacurium—Hypotension—Dexamethasone—multiple sclerosis	0.000365	0.004	CcSEcCtD
Mivacurium—Hypotension—Betamethasone—multiple sclerosis	0.000365	0.004	CcSEcCtD
Mivacurium—Angiopathy—Methotrexate—multiple sclerosis	0.000363	0.00398	CcSEcCtD
Mivacurium—Immune system disorder—Methotrexate—multiple sclerosis	0.000361	0.00396	CcSEcCtD
Mivacurium—Mediastinal disorder—Methotrexate—multiple sclerosis	0.00036	0.00395	CcSEcCtD
Mivacurium—Rash—Mitoxantrone—multiple sclerosis	0.00036	0.00394	CcSEcCtD
Mivacurium—Dermatitis—Mitoxantrone—multiple sclerosis	0.000359	0.00394	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000352	0.00386	CcSEcCtD
Mivacurium—Erythema—Methotrexate—multiple sclerosis	0.000348	0.00382	CcSEcCtD
Mivacurium—Urticaria—Triamcinolone—multiple sclerosis	0.000342	0.00375	CcSEcCtD
Mivacurium—Urticaria—Methylprednisolone—multiple sclerosis	0.000341	0.00374	CcSEcCtD
Mivacurium—Anaphylactic shock—Prednisone—multiple sclerosis	0.00034	0.00373	CcSEcCtD
Mivacurium—Tachycardia—Prednisone—multiple sclerosis	0.000332	0.00364	CcSEcCtD
Mivacurium—Skin disorder—Prednisone—multiple sclerosis	0.00033	0.00362	CcSEcCtD
Mivacurium—Urticaria—Dexamethasone—multiple sclerosis	0.00031	0.0034	CcSEcCtD
Mivacurium—Urticaria—Betamethasone—multiple sclerosis	0.00031	0.0034	CcSEcCtD
Mivacurium—Dizziness—Prednisolone—multiple sclerosis	0.000309	0.00339	CcSEcCtD
Mivacurium—Rash—Prednisolone—multiple sclerosis	0.000295	0.00324	CcSEcCtD
Mivacurium—Dermatitis—Prednisolone—multiple sclerosis	0.000295	0.00323	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000294	0.00323	CcSEcCtD
Mivacurium—Dizziness—Triamcinolone—multiple sclerosis	0.000284	0.00312	CcSEcCtD
Mivacurium—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000284	0.00312	CcSEcCtD
Mivacurium—Dizziness—Methylprednisolone—multiple sclerosis	0.000284	0.00311	CcSEcCtD
Mivacurium—Skin disorder—Methotrexate—multiple sclerosis	0.000276	0.00303	CcSEcCtD
Mivacurium—Rash—Triamcinolone—multiple sclerosis	0.000271	0.00298	CcSEcCtD
Mivacurium—Dermatitis—Triamcinolone—multiple sclerosis	0.000271	0.00297	CcSEcCtD
Mivacurium—Rash—Methylprednisolone—multiple sclerosis	0.000271	0.00297	CcSEcCtD
Mivacurium—Dermatitis—Methylprednisolone—multiple sclerosis	0.00027	0.00297	CcSEcCtD
Mivacurium—Urticaria—Prednisone—multiple sclerosis	0.00027	0.00296	CcSEcCtD
Mivacurium—Hypotension—Methotrexate—multiple sclerosis	0.000265	0.00291	CcSEcCtD
Mivacurium—Dizziness—Betamethasone—multiple sclerosis	0.000258	0.00283	CcSEcCtD
Mivacurium—Dizziness—Dexamethasone—multiple sclerosis	0.000258	0.00283	CcSEcCtD
Mivacurium—Rash—Betamethasone—multiple sclerosis	0.000246	0.0027	CcSEcCtD
Mivacurium—Rash—Dexamethasone—multiple sclerosis	0.000246	0.0027	CcSEcCtD
Mivacurium—Dermatitis—Dexamethasone—multiple sclerosis	0.000246	0.0027	CcSEcCtD
Mivacurium—Dermatitis—Betamethasone—multiple sclerosis	0.000246	0.0027	CcSEcCtD
Mivacurium—Urticaria—Methotrexate—multiple sclerosis	0.000226	0.00248	CcSEcCtD
Mivacurium—Dizziness—Prednisone—multiple sclerosis	0.000225	0.00247	CcSEcCtD
Mivacurium—Rash—Prednisone—multiple sclerosis	0.000214	0.00235	CcSEcCtD
Mivacurium—Dermatitis—Prednisone—multiple sclerosis	0.000214	0.00235	CcSEcCtD
Mivacurium—Dizziness—Methotrexate—multiple sclerosis	0.000188	0.00206	CcSEcCtD
Mivacurium—Rash—Methotrexate—multiple sclerosis	0.000179	0.00196	CcSEcCtD
Mivacurium—Dermatitis—Methotrexate—multiple sclerosis	0.000179	0.00196	CcSEcCtD
